Xanax, Valium, Similar Drugs Linked To Opioid Overdose Risk: Study

|

The use of benzodiazepines, such as Xanax and Valium, may increase the risk of an opioid overdose, according to the findings of new research. 

In a study published earlier this month in the medical journal The BMJ, researchers indicate that patients using benzodiazepines and opioid pain medications at the same time were more likely to need medical care in an emergency room or be admitted to the hospital for opioid overdose.

Researchers from Stanford University School of Medicine conducted a retrospective analysis of administrative health claims from 2001 to 2013 from database information. It focused on concurrent benzodiazepine and opioid use.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Data for more than 315,000 privately insured patients ages 18 to 64 who were continuously enrolled in a health plan with medical and pharmacy benefits were examined during the study period. Patients filled at least one prescription for an opioid. Concurrent use was defined as an overlap of at least one day during prescription use.

In 2001, nine percent of narcotic painkiller users also used benzodiazepines, such as Valium and Xanax. That number increased to 17% by 2013.

The study indicated patients who used both opioids and benzodiazepines simultaneously had an increased risk of emergency room visit or hospital admission for opioid overdose.

Nearly 30% of fatal opioid overdoses involve benzodiazepines. This study indicated those two are often used together, increasing the odds of a fatal overdose. The FDA issued a black box warning in 2016 for the combined use of the two drugs, citing severe health risks, including death.

Study authors said eliminating concurrent use of opioids and benzodiazepines could help reduce the risk of ER visits and hospital admissions for opioid overdose by 15%.

Researchers note that other studies have shown 47% of patients in methadone treatments in Spain, 52% of methadone patients in Switzerland, and high rates of heroin users in Australia also use benzodiazepines at the same time.

Nearly 30% of Veterans Health Administration patients who were prescribed opioids also received prescriptions for benzodiazepines at the same time, according to the findings.

Media attention focusing on narcotic painkiller use has increased as the opioid overdose epidemic has worsened, as use of high-potency opioids, like OxyContin, increased dramatically.

Researchers said the increase in concurrent benzodiazepine use was mainly driven by an increased use of opioids among intermittent users, or users who were not chronic users.

Benzodiazepines, like Xanax, are a class of drugs that work on the brain’s neurotransmitters. They cause sedative and hypnotic effects and are often used to treat anxiety, insomnia and seizures. Benzodiazepines also increase the effects opioids have on depressing respiratory function.

Written by: Martha Garcia

Health & Medical Research Writer

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl.
Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.
Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.